Advancements in CMV-management post HSCT
Saturday, October 26th, 2024
12:45-14:15
90 min
Chair: Prof. Dr. Igor-Wolfgang Blau (Berlin)
| AGENDA | |
|---|---|
| 10 min | Introduction |
| 20 min | Exploring Charité’s Experiences: Insights from Case Studies and Case Examples Prof. Dr. Igor-Wolfgang Blau (Charité Universitätsmedizin Berlin, Germany) |
| 25 min | Optimal Timing for Prophylaxis: Balancing 100-Day vs 200-Day Prophylaxis Dr. Elisa Sala (Universitätsklinikum Ulm, Germany) |
| 25 min | Current Debates in Graft-versus-Host Disease: ATG vs. PostCy and Infection Risk with a Focus on CMV Priv.-Doz. Dr. Thomas Schroeder (Universitätsklinikum Essen, Germany) |
| 10 min | Conclusion |
